Other COVID-19 Resources

Safety of COVID-19 vaccines – April updates

ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines

EMA recommends authorisation of COVID-19 medicine Evusheld

EMA recommends authorisation of booster doses of Comirnaty from 12 years of age

EMA recommends approval of Spikevax for children aged 6 to 11

The International Covid-19 Blood Cancer Coalition (ICBCC) Statement
Protecting immunocompromised blood cancer patients during the COVID-19 pandemic 
Read more>

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network Read more >

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Read more >

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) Read more >

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Read more >

Management of hematologic disease under the COVID-19 pandemic: Experience from China
(in collaboration with the Chinese Society of Hematology) 
Read more >

Clinical practice resources

Resources from other professional societies

Literature resources on main medical journals

Monitoring the pandemic

International health and medicines organizations

Other related webinars: